InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
Stephen P. Carey
29 Oct 2026
SVP & CFO
Sold on a plan
2,850
$72.87
$207.68K
Nikhil Lalwani
15 Oct 2026
President & CEO
Sold on a plan
5,400
$71.89
$388.21K
Meredith Cook
13 Oct 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$73.59
$36.80K
Stephen P. Carey
29 Sep 2026
SVP & CFO
Sold on a plan
2,850
$73.00
$208.05K
Nikhil Lalwani
15 Sep 2026
President & CEO
Sold on a plan
5,400
$71.00
$383.40K
Meredith Cook
14 Sep 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$70.79
$35.40K
Jeanne Thoma
11 Sep 2026
Director
Sold on a plan
1,000
$71.53
$71.53K
Stephen P. Carey
31 Aug 2026
SVP & CFO
Sold on a plan
2,850
$72.80
$207.48K
Nikhil Lalwani
25 Aug 2026
President & CEO
Sold on a plan
5,400
$74.30
$401.22K
Meredith Cook
13 Aug 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$75.48
$37.74K
Ori Gutwerg
10 Aug 2026
SVP, Generics
Sell
3,162
$77.00
$243.47K
Stephen P. Carey
29 Jul 2026
SVP & CFO
Sold on a plan
2,850
$81.36
$231.88K
Meredith Cook
13 Jul 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$81.84
$40.92K
Stephen P. Carey
2 Jul 2026
SVP & CFO
Sold after exercise
3,313
$86.00
$284.92K
Stephen P. Carey
29 Jun 2026
SVP & CFO
Sold on a plan
2,850
$84.12
$239.74K
Meredith Cook
12 Jun 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$82.03
$41.02K
Thomas Haughey
8 Jun 2026
Director
Sold on a plan
2,000
$80.88
$161.76K
Stephen P. Carey
5 Jun 2026
SVP & CFO
Sold after exercise
3,312
$80.00
$264.96K
Meredith Cook
13 May 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$78.16
$39.08K
Patrick D Walsh
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Ori Gutwerg
12 May 2026
SVP, Generics
Sell
2,772
$79.50
$220.37K
Thomas Andrew Rowland
12 May 2026
SVP, Head - Established Brands
Sell
459
$79.21
$36.36K
Nikhil Lalwani
11 May 2026
President & CEO
Sell
55,000
$77.57
$4.27M
Patrick D Walsh
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Meredith Cook
13 Apr 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$77.95
$38.98K
Meredith Cook
13 Mar 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$72.62
$36.31K
Christopher Mutz
13 Mar 2026
Head of Rare Disease
Sold on a plan
3,162
$71.64
$226.53K
Thomas Andrew Rowland
11 Mar 2026
SVP, Head - Established Brands
Sell
4,772
$74.91
$357.47K
Krista Davis
9 Mar 2026
SVP, Chief HR Officer
Sold on a plan
5,087
$74.13
$377.10K
Christopher Mutz
9 Mar 2026
Head of Rare Disease
Sold on a plan
3,602
$74.18
$267.20K
Krista Davis
6 Mar 2026
SVP, Chief HR Officer
Sold on a plan
1,485
$75.00
$111.38K
Christopher Mutz
6 Mar 2026
Head of Rare Disease
Sold on a plan
2,121
$74.22
$157.42K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
4,000
$75.56
$302.24K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
3,312
$75.42
$249.79K
Patrick D Walsh
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Ori Gutwerg
3 Mar 2026
SVP, Generics
Sell
2,060
$76.50
$157.59K
Christopher Mutz
2 Mar 2026
Head of Rare Disease
Sold on a plan
417
$74.00
$30.86K
Krista Davis
20 Feb 2026
SVP, Chief HR Officer
Sold on a plan
1,730
$77.99
$134.92K
Christopher Mutz
20 Feb 2026
Head of Rare Disease
Sold on a plan
5,323
$78.02
$415.30K
Krista Davis
19 Feb 2026
SVP, Chief HR Officer
Sold on a plan
2,084
$77.53
$161.57K
Meredith Cook
13 Feb 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$76.80
$38.40K
Christopher Mutz
12 Feb 2026
Head of Rare Disease
Sold on a plan
7,032
$76.55
$538.30K
Meredith Cook
13 Jan 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$84.33
$42.17K
Krista Davis
18 Dec 2025
SVP, Chief HR Officer
Sold on a plan
1,622
$82.40
$133.65K
Meredith Cook
12 Dec 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$82.32
$32.93K
Renee P Tannenbaum
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Meredith Cook
13 Nov 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$87.27
$34.91K
Chad Gassert
13 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
94
$88.00
$8.27K
Patrick D Walsh
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Chad Gassert
12 Nov 2025
SVP - Corp. Dev. & Strategy
Sell indirect
14,642
$89.07
$1.30M

What was left out

Form 4 filings counted 77
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 389,730
History held since 29 Sep 2006